GLP-1 agonists are a class of drugs that are widely used to treat type 2 diabetes. Drugs of this type have been shown to improve glycemic control and also to decrease systolic blood pressure, decrease triglycerides, increase sodium excretion, and promote weight loss. Exenatide is a popular GLP-1 agonist that has been used for over 10 years; while effective, it is inconvenient for many patients as it requires twice-daily injections. Now, a new version, BYDUREON® BCise™, is available.  It can be injected just once a week, offering the same benefits with much greater convenience. Read more